Sonova (OTCMKTS:SONVY) Shares Up 8.9% – Here’s What Happened

Sonova Holding (OTCMKTS:SONVY – Get Free Report) traded up 8.9% during trading on Tuesday . The company traded as high as $49.68 and last traded at $49.43. 820 shares changed hands during mid-day trading, a decline of 98% from the average session volume of 41,011 shares. The stock had previously closed at $45.39.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on SONVY. Citigroup reissued a “sell” rating on shares of Sonova in a report on Wednesday, May 13th. Jefferies Financial Group lowered shares of Sonova from a “hold” rating to a “moderate sell” rating in a research report on Wednesday, March 18th. Zacks Research upgraded shares of Sonova from a “strong sell” rating to a “hold” rating in a research note on Monday, February 9th. Finally, BNP Paribas Exane raised shares of Sonova from a “strong sell” rating to a “strong-buy” rating in a report on Tuesday, March 10th. Two equities research analysts have rated the stock with a Strong Buy rating, one has given a Buy rating, four have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold”.

Get Sonova alerts:

Check Out Our Latest Research Report on SONVY

Sonova Stock Up 1.8%

The company has a current ratio of 1.24, a quick ratio of 0.91 and a debt-to-equity ratio of 0.51. The stock’s fifty day moving average price is $45.97 and its two-hundred day moving average price is $50.00.

Sonova Company Profile

(Get Free Report)

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.

Featured Articles

• Five stocks we like better than Sonova
• Why Home Depot’s Sell-Off Could Become a Huge Opportunity
• The Pentagon’s AI Pivot Supercharges Defense Stocks
• AAPL: Forget the iPhone—Services Will Drive the Next Phase of Growth
• Ackman and Berkshire Are Betting Against Each Other on AI

Receive News & Ratings for Sonova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonova and related companies with MarketBeat.com's FREE daily email newsletter.